ZTS
NYSE · Pharmaceuticals
Zoetis Inc
$82.11
-7.09 (-7.95%)
ZTS News3 articles
Zoetis Shares Near 52-Week Low as Guidance Cut, Buybacks Bolster EPS
Zoetis shares fell 5.97% to $72.66, near a 52-week low, after the company reduced its 2026 guidance. Buybacks helped adjusted EPS rise 5% despite a 1% drop in adjusted net income.
Zoetis Shares Tumble After Pet Care Sales Slump, Guidance Cut
Zoetis lowered its 2026 revenue and profit forecasts after U.S. pet product sales dropped 11% in Q1, missing analyst estimates and sending shares down 21%.
Zoetis Shares Plunge 20% on Weak Pet Owner Spending, Lowered Guidance
Zoetis shares plunged 20% after cutting its 2026 outlook and missing Q1 estimates, as U.S. pet owners cut back on vet visits and premium treatments, intensifying competition.